15Dec
Life Sciences Dealmaking Symposium: Powering through the Pandemic: Trends in Early-Stage Investment
The pursuit of progress during these unprecedented times has led to a surge in life sciences investment and funding for early stage companies. Investors are on the lookout for the next big innovation while also navigating new ways of sourcing and managing portfolio companies. Our panel of experienced early-stage investors discussed the top trends in this push for advancement, including sectors attracting the most dollars in today’s challenging business landscape, key issues that early stage...
By:
McDermott Will & Emery
Related
The FTI Journal continues its look at opportunities for private equity in distressed M&A given the p...
Read More >
Cimarron Healthcare Capital has announced it has completed its acquisition of Ascent Behavioral Heal...
Read More >
The tentative agenda for That 401(k) National Conference at Walt Disney World Swan on March 10-11, 2...
Read More >
With a recent uptick in mergers and transactions, we thought it would be worthwhile to provide a ref...
Read More >
When the pandemic broke, hand brakes were swiftly pulled, and just like that, the record-breaking bu...
Read More >
El 9 de enero de 2020, el Instituto Nacional de Estadística y Geografía (INEGI) publicó los nuevos v...
Read More >